{"disease":{"id":"braf-v600e-mutation-positive-unresectable-advanced-or-recurrent-solid-tumor","name":"braf v600e mutation positive unresectable advanced or recurrent solid tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06262919","title":"Special Drug Use-results Surveillance of Tafinlar/Mekinist","phase":"","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}